Researchers in China used machine learning to create diagnostic and prognostic models to aid in identifying idiopathic ...

IPF treatment candidate CS014 was safe and well tolerated in volunteers in a Phase 1 trial, and showed early promise for ...

Columnist Sam Kirton describes how daunting an IPF prognosis can be — but also how things are looking up for patients today.

Pulmonary fibrosis is a disease marked by scarring — or fibrosis — of tissue deep in the lungs, making breathing difficult.

A flash flood can pose unique risks for PF patients, says columnist Sam Kirton, who shares several ways to prepare for such an emergency.

Sam Kirton started his column in November 2021 and writes from his home at Lake Anna, Virginia, where he lives with his wife Susan. His diagnosis at age 59 with idiopathic pulmonary fibrosis in ...

Read about idiopathic pulmonary fibrosis (IPF) — its risk factors, symptoms, and current ways of treating this interstitial lung disease.

GRI-0621, an experimental oral therapy for IPF, has so far been tolerated well in an ongoing Phase 2 clinical trial.

Read about spirometry, a test that measures lung function in pulmonary fibrosis, asthma and COPD. It involves inhaling and exhaling to check air flow.

There is currently no cure for pulmonary fibrosis (PF). However, medication and other treatment options can help improve patients’ quality of life, ease symptoms, and slow the disease’s progression.

Looking for information about different types of pulmonary fibrosis? Read about IPF, familial PF, and other types of pulmonary fibrosis here.